Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: IntellaSys’ 40-core Processor Technology Creates Industry Benchmark for Embedded

Re: IntellaSys’ 40-core Processor Technology Creates Industry Benchmark for Embedded

posted on Sep 24, 2008 08:46AM

The cost to collect a license fee will drop drastically when the patents are validated



IMO that should read "if patents are validated". While I, along with everyone else, would love to see a quick, affirmative response back from the PTO, but no one can guarantee that.

I think by RG again saying the patent validation process is complex, lengthy process and by his active M&A strategy that he is preparing PTSC for the future. Even if that future does not include validated patents (which I absolutely hope it does), this company is being put on a path for it to succeed.

Share
New Message
Please login to post a reply